Loading company…
SJ CHEMMEDITECH develops drug delivery system-based cancer therapies targeting the tumor microenvironment.
Based in South Korea, SJ CHEMMEDITECH develops drug delivery system-based cancer treatments that regulate the tumor microenvironment. Its lead program targets pancreatic cancer, with potential applications in bile duct, lung, and breast cancers. In August 2026, it raised an undisclosed amount of venture funding from CNT Tech. The company is optimizing candidates and validating delivery efficiency as it prepares for preclinical development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in